Our Services
Medical Information
Helpful Resources
Published on: 9/23/2026
For most adults, the RSV vaccine is currently given as a single lifetime dose, and the CDC does not recommend annual or repeat doses at this time. Protection has been shown to last through at least two to three RSV seasons, which is why revaccination is not advised even if several years have passed. There are important exceptions, including pregnancy, where a dose is recommended during each pregnancy, and infants, who may receive a protective antibody shot rather than a vaccine each season. Timing, age eligibility, and risk factors all change what applies to you, so there are several details to consider below. See the complete answer below before assuming one shot covers you for life.
Because RSV symptoms overlap heavily with colds, flu, and COVID-19, it can be hard to know whether what you are feeling is minor or worth urgent attention, especially if you are over 50, pregnant, or caring for an infant. Taking a few minutes to complete a free, instant, online symptom check can help you organize your symptoms, understand possible causes, and decide whether to monitor at home or contact a clinician next.
Last reviewed for medical accuracy: 09/23/2025
Respiratory syncytial virus (RSV) causes seasonal winter respiratory illness in infants, older adults and pregnant people. You may be asking: is the RSV vaccine a one time shot? The short answer is that most current RSV vaccines are given as a single dose per season or per pregnancy. Below, we break down who needs which dose, when, and why.
Respiratory syncytial virus (RSV) can cause everything from a mild cold to serious lung infections like bronchiolitis or pneumonia.
Unvaccinated people in these groups are more likely to need hospital care. Vaccination helps reduce severe RSV infection.
Today’s FDA-approved RSV preventive products fall into two main categories:
Adult/adolescent RSV vaccines
• Arexvy (GSK) – for ages 60+
• Abrysvo (Pfizer) – for ages 60+ and maternal immunization
Monoclonal antibody for infants
• Nirsevimab (Beyfortus) – for infants under 8 months at season start or under 19 months with risk factors
Bottom line: You don’t get a lifetime “one and done” RSV shot—current guidance is a single dose for each RSV season or pregnancy. Future studies will tell us if annual boosters are needed, similar to flu shots.
As data accumulates, recommendations may evolve. Stay tuned to the CDC and FDA for updates.
Side effects are generally mild and short-lived:
Serious allergic reactions are rare. Always report any concerns to your healthcare provider.
If you ever feel unwell or notice severe breathing problems, chest pain, high fever or confusion, speak to a doctor immediately, as these could be signs of a serious condition.
Not sure if your cough or fever is RSV or something else? Try a free, online symptom check, using the doctor approved Ubie Symptom Checker to help guide your next steps. It’s quick, confidential and doctor-designed.
Stay informed through reliable sources like the CDC, FDA and your healthcare provider. Preventive care, including timely RSV vaccination, is one of the best tools to protect you and your loved ones each season.
(References)
* Chu HY, Englund JA. Maternal immunization. Birth Defects Res. 2017 Mar 15;109(5):379-386. doi: 10.1002/bdra.23547. PMID: 28398678.
* Qiu X, Xu S, Lu Y, Luo Z, Yan Y, Wang C, Ji J. Development of mRNA vaccines against respiratory syncytial virus (RSV). Cytokine Growth Factor Rev. 2022 Dec;68:37-53. doi: 10.1016/j.cytogfr.2022.10.001. Epub 2022 Oct 13. PMID: 36280532.
* Papi A, Ison MG, Langley JM, Lee DG, Leroux-Roels I, Martinon-Torres F, Schwarz TF, van Zyl-Smit RN, Campora L, Dezutter N, de Schrevel N, Fissette L, David MP, Van der Wielen M, Kostanyan L, Hulstrøm V, AReSVi-006 Study Group. Respiratory Syncytial Virus Prefusion F Protein Vaccine in Older Adults. N Engl J Med. 2023 Feb 16;388(7):595-608. doi: 10.1056/NEJMoa2209604. PMID: 36791160.
* Wilson E, Goswami J, Baqui AH, Doreski PA, Perez-Marc G, Zaman K, Monroy J, Duncan CJA, Ujiie M, Rämet M, Pérez-Breva L, Falsey AR, Walsh EE, Dhar R, Wilson L, Du J, Ghaswalla P, Kapoor A, Lan L, Mehta S, Mithani R, Panozzo CA, Simorellis AK, Kuter BJ, Schödel F, Huang W, Reuter C, Slobod K, Stoszek SK, Shaw CA, Miller JM, Das R, Chen GL, ConquerRSV Study Group. Efficacy and Safety of an mRNA-Based RSV PreF Vaccine in Older Adults. N Engl J Med. 2023 Dec 14;389(24):2233-2244. doi: 10.1056/NEJMoa2307079. PMID: 38091530.
* Ison MG, Papi A, Athan E, Feldman RG, Langley JM, Lee DG, Leroux-Roels I, Martinon-Torres F, Schwarz TF, van Zyl-Smit RN, Verheust C, Dezutter N, Gruselle O, Fissette L, David MP, Kostanyan L, Hulstrøm V, Olivier A, Van der Wielen M, Descamps D, AReSVi-006 Study Group. Efficacy and Safety of Respiratory Syncytial Virus (RSV) Prefusion F Protein Vaccine (RSVPreF3 OA) in Older Adults Over 2 RSV Seasons. Clin Infect Dis. 2024 Jun 14;78(6):1732-1744. doi: 10.1093/cid/ciae010. PMID: 38253338; PMCID: PMC11175669.
* Britton A, Roper LE, Kotton CN, Hutton DW, Fleming-Dutra KE, Godfrey M, Ortega-Sanchez IR, Broder KR, Talbot HK, Long SS, Havers FP, Melgar M. Use of Respiratory Syncytial Virus Vaccines in Adults Aged ≥60 Years: Updated Recommendations of the Advisory Committee on Immunization Practices - United States, 2024. MMWR Morb Mortal Wkly Rep. 2024 Aug 15;73(32):696-702. doi: 10.15585/mmwr.mm7332e1. Epub 2024 Aug 15. PMID: 39146277.
* Ison MG, Papi A, Athan E, Feldman RG, Langley JM, Lee DG, Leroux-Roels I, Martinon-Torres F, Schwarz TF, van Zyl-Smit RN, Cuadripani S, Deraedt Q, Dezutter N, Gerard C, Fissette L, Xavier S, David MP, Olivier A, Van der Wielen M, Descamps D, AReSVi-006 study group. Efficacy, safety, and immunogenicity of the AS01(E)-adjuvanted respiratory syncytial virus prefusion F protein vaccine (RSVPreF3 OA) in older adults over three respiratory syncytial virus seasons (AReSVi-006): a multicentre, randomised, observer-blinded, placebo-controlled, phase 3 trial. Lancet Respir Med. 2025 Jun;13(6):517-529. doi: 10.1016/S2213-2600(25)00048-7. Epub 2025 Apr 14. PMID: 40245915.
* Paes BA, Bacchini F, Bracht M, Rodgers-Gray B, Carbonell-Estrany X. Respiratory syncytial virus immunization in children: The old, the new and what's just around the corner. Hum Vaccin Immunother. 2025 Dec;21(1):2521920. doi: 10.1080/21645515.2025.2521920. Epub 2025 Jun 24. PMID: 40555690; PMCID: PMC12785216.
* Surie D, Self WH, Yuengling KA, Lauring AS, Zhu Y, Safdar B, Ginde AA, Simon SJ, Peltan ID, Brown SM, Gaglani M, Ghamande S, Columbus C, Mohr NM, Gibbs KW, Hager DN, Prekker M, Gong MN, Mohamed A, Johnson NJ, Steingrub JS, Khan A, Duggal A, Gordon AJ, Qadir N, Chang SY, Mallow C, Felzer JR, Kwon JH, Exline MC, Vaughn IA, Ramesh M, Papalambros L, Mosier JM, Harris ES, Baughman A, Cornelison SA, Blair PW, Johnson CA, Lewis NM, Ellington S, Grijalva CG, Talbot HK, Casey JD, Halasa N, Chappell JD, Rutkowski RE, Ma KC, Dawood FS, Investigating Respiratory Viruses in the Acutely Ill (IVY) Network. RSV Vaccine Effectiveness Against Hospitalization Among US Adults Aged 60 Years or Older During 2 Seasons. JAMA. 2025 Oct 28;334(16):1442-1451. doi: 10.1001/jama.2025.15896. PMID: 40884491; PMCID: PMC12398767.
* Scott J, Abers MS, Marwah HK, McCann NC, Meyerowitz EA, Richterman A, Fleming DF, Holmes EJ, Moat LE, Redepenning SG, Smith EA, Stoddart CJ, Sundaram ME, Ulrich AK, Alba C, Anderson CJ, Arpey MK, Borre E, Ladines-Lim J, Mehr AJ, Rich K, Watts C, Basta NE, Jarolimova J, Walensky RP, Dugdale CM. Updated Evidence for Covid-19, RSV, and Influenza Vaccines for 2025-2026. N Engl J Med. 2025 Dec 4;393(22):2221-2242. doi: 10.1056/NEJMsa2514268. Epub 2025 Oct 29. PMID: 41160817.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.